Insider buying on Jul 28, 2026
Insiders at 19 companies reported 32 open-market buys of their own stock on Jul 28, 2026. Plan trades are left out.
Newest first
WhoTradeCompanyValueTradedThe stock’s closing price from the first session on or after the trade day to the latest close, with the S&P 500 over the same days. A fact about the stock, not a result anyone earned.
Behzad AghazadehDirectorBoughtRaised their holding by 0.3%
Scribe TherapeuticsSCTX$144.3K7,905 shares at $18.25Jul 2890d agoStock since trade+9.7%Jul 28, 2026 close $18.06 → Oct 20, 2026 close $19.81. S&P 500 +3.8% over the same days.
Behzad AghazadehDirectorBoughtRaised their holding by 1.6%
Scribe TherapeuticsSCTX$1.12M50,000 shares at $22.31Jul 2494d agoStock since trade−8.5%Jul 24, 2026 close $21.65 → Oct 20, 2026 close $19.81. S&P 500 +4.1% over the same days.
Behzad AghazadehDirectorBoughtRaised their holding by 335%
Scribe TherapeuticsSCTX$35M2,333,333 shares at $15.00Jul 2494d agoStock since trade−8.5%Jul 24, 2026 close $21.65 → Oct 20, 2026 close $19.81. S&P 500 +4.1% over the same days.
Troy CoxDirectorBoughtNew holding
MapLight TherapeuticsMPLT$148.7K15,620 shares at $9.52Jul 2890d agoStock since trade−37.8%Jul 28, 2026 close $12.31 → Oct 26, 2026 close $7.66. S&P 500 +3.3% over the same days.
Thomas M. MoriartyEVP, M&A and Corporate AffairsBoughtRaised their holding by 123%
Albertsons CompaniesACI$1.96M170,500 shares at $11.51Jul 2791d agoStock since trade+22.8%Jul 27, 2026 close $11.37 → Oct 23, 2026 close $13.96. S&P 500 +2.8% over the same days.
Saba Capital ManagementMajor shareholderBought
New Germany FundGF$3.7K325 shares at $11.28Jul 2791d agoStock since trade−9.7%Jul 27, 2026 close $11.28 → Oct 26, 2026 close $10.19. S&P 500 +3.6% over the same days.
Dennis MatheisDirectorBoughtRaised their holding by 50%
DarioHealthDRIO$100K14,430 shares at $6.93Jul 2395d agoStock since trade−49.5%Jul 23, 2026 close $7.47 → Oct 23, 2026 close $3.77. S&P 500 +3.0% over the same days.
RA Capital ManagementDirectorBoughtRaised their holding by 0.2%
Artiva BiotherapeuticsARTV$412.8K41,319 shares at $9.99Jul 2494d agoStock since trade−38.6%Jul 24, 2026 close $10.03 → Oct 26, 2026 close $6.16. S&P 500 +3.6% over the same days.
Brien Raymond V. O. IIIDirectorBoughtRaised their holding by 30%
CVB FinancialCVBF$455.3K20,000 shares at $22.77Jul 2890d agoStock since trade+0.5%Jul 28, 2026 close $22.80 → Oct 26, 2026 close $22.91. S&P 500 +3.3% over the same days.
Erez MeltzerChief Executive OfficerBoughtNew holding
Nano-X ImagingNNOX$33.5K36,000 shares at $0.9300Jul 2791d agoStock since trade−58.0%Jul 27, 2026 close $0.89 → Oct 23, 2026 close $0.37. S&P 500 +2.8% over the same days.